Jpmorgan Chase & CO Harmony Biosciences Holdings, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 484,797 shares of HRMY stock, worth $12.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
484,797
Previous 235,882 105.53%
Holding current value
$12.8 Million
Previous $8.12 Million 98.25%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$32.18 - $40.46 $8.01 Million - $10.1 Million
248,915 Added 105.53%
484,797 $16.1 Million
Q4 2024

Feb 12, 2025
BUY
$31.86 - $41.49 $173,764 - $226,286
5,454 Added 2.37%
235,882 $8.12 Million
Q3 2024

Dec 26, 2024
BUY
$30.0 - $39.95 $2.81 Million - $3.74 Million
93,622 Added 68.43%
230,428 $9.21 Million
Q3 2024

Nov 08, 2024
BUY
$30.0 - $39.95 $2.81 Million - $3.74 Million
93,622 Added 68.43%
230,428 $9.21 Million
Q2 2024

Dec 26, 2024
SELL
$28.81 - $33.01 $2.7 Million - $3.09 Million
-93,622 Reduced 40.63%
136,806 $4.13 Million
Q2 2024

Aug 12, 2024
BUY
$28.81 - $33.01 $2.71 Million - $3.1 Million
93,967 Added 219.35%
136,806 $4.13 Million
Q1 2024

Dec 26, 2024
SELL
$29.93 - $35.06 $5.61 Million - $6.58 Million
-187,589 Reduced 81.41%
42,839 $1.44 Million
Q1 2024

May 10, 2024
SELL
$29.93 - $35.06 $2.4 Million - $2.81 Million
-80,065 Reduced 65.14%
42,839 $1.44 Million
Q4 2023

Dec 26, 2024
SELL
$19.2 - $33.78 $2.06 Million - $3.63 Million
-107,524 Reduced 46.66%
122,904 $3.97 Million
Q4 2023

Feb 12, 2024
BUY
$19.2 - $33.78 $845,491 - $1.49 Million
44,036 Added 55.84%
122,904 $3.97 Million
Q3 2023

Nov 14, 2023
SELL
$31.89 - $39.03 $773,013 - $946,087
-24,240 Reduced 23.51%
78,868 $2.58 Million
Q2 2023

Aug 11, 2023
BUY
$30.5 - $37.4 $1.49 Million - $1.83 Million
48,914 Added 90.26%
103,108 $3.63 Million
Q1 2023

May 18, 2023
BUY
$30.8 - $53.92 $1.07 Million - $1.87 Million
34,613 Added 176.77%
54,194 $1.77 Million
Q1 2023

May 11, 2023
SELL
$30.8 - $53.92 $2.26 Million - $3.95 Million
-73,224 Reduced 78.9%
19,581 $639,000
Q4 2022

Feb 13, 2023
SELL
$45.4 - $60.91 $1.07 Million - $1.43 Million
-23,480 Reduced 20.19%
92,805 $5.11 Million
Q3 2022

Nov 14, 2022
BUY
$42.06 - $55.45 $812,683 - $1.07 Million
19,322 Added 19.93%
116,285 $5.15 Million
Q2 2022

Aug 11, 2022
BUY
$33.54 - $52.15 $2.4 Million - $3.73 Million
71,620 Added 282.6%
96,963 $4.73 Million
Q1 2022

May 11, 2022
BUY
$33.14 - $51.13 $99,983 - $154,259
3,017 Added 13.51%
25,343 $1.23 Million
Q4 2021

Feb 10, 2022
BUY
$34.09 - $43.91 $436,556 - $562,311
12,806 Added 134.52%
22,326 $953,000
Q3 2021

Nov 12, 2021
BUY
$25.68 - $38.61 $244,473 - $367,567
9,520 New
9,520 $365,000

Others Institutions Holding HRMY

# of Institutions
290
Shares Held
46.3M
Call Options Held
316K
Put Options Held
69.9K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.56B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email